Cargando…
The G(516)T CYP2B6 Germline Polymorphism Affects the Risk of Acute Myeloid Leukemia and Is Associated with Specific Chromosomal Abnormalities
The etiology of acute myeloid leukemia (AML) underlies the influence of genetic variants in candidate genes. The CYP2B6 enzyme detoxifies many genotoxic xenobiotics, protecting cells from oxidative damage. The CYP2B6 gene is subjected to a single-nucleotide polymorphism (G(516)T) with heterozygotes...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933334/ https://www.ncbi.nlm.nih.gov/pubmed/24586425 http://dx.doi.org/10.1371/journal.pone.0088879 |
_version_ | 1782304916406009856 |
---|---|
author | Daraki, Aggeliki Zachaki, Sophia Koromila, Theodora Diamantopoulou, Paraskevi Pantelias, Gabriel E. Sambani, Constantina Aleporou, Vasiliki Kollia, Panagoula Manola, Kalliopi N. |
author_facet | Daraki, Aggeliki Zachaki, Sophia Koromila, Theodora Diamantopoulou, Paraskevi Pantelias, Gabriel E. Sambani, Constantina Aleporou, Vasiliki Kollia, Panagoula Manola, Kalliopi N. |
author_sort | Daraki, Aggeliki |
collection | PubMed |
description | The etiology of acute myeloid leukemia (AML) underlies the influence of genetic variants in candidate genes. The CYP2B6 enzyme detoxifies many genotoxic xenobiotics, protecting cells from oxidative damage. The CYP2B6 gene is subjected to a single-nucleotide polymorphism (G(516)T) with heterozygotes (GT) and homozygotes (TT) presenting decreased enzymatic activity. This case-control study aimed to investigate the association of CYP2B6 G(516)T polymorphism with the susceptibility of AML and its cytogenetic and clinical characteristics. Genotyping was performed on 619 AML patients and 430 healthy individuals using RCR-RFLP and a novel LightSNip assay. The major finding was a statistically higher frequency of the variant genotypes (GT and TT) in patients compared to the controls (GT:38.8% vs 29.8% and TT:9.3% vs 5.3% respectively) (p<0.001). More specifically, a significantly higher frequency of GT+TT genotypes in de novo AML patients (46.6%) and an immensely high frequency of TT in secondary AML (s-AML) (20.5%) were observed. The statistical analysis showed that the variant T allele was approximately 1.5-fold and 2.4-fold higher in de novo and s-AML respectively than controls. Concerning FAB subtypes, the T allele presented an almost 2-fold increased in AML-M2. Interestingly, a higher incidence of the TT genotype was observed in patients with abnormal karyotypes. In particular, positive correlations of the mutant allele were found in patients carrying specific chromosomal aberrations [-7/del(7q), -5/del(5q), +8, +21 or t(8;21)], complex or monosomal karyotypes. Finally, a strikingly higher frequency of TT genotype was also observed in patients stratified to the poor risk group. In conclusion, our results provide evidence for the involvement of the CYP2B6 polymorphism in AML susceptibility and suggest a possible role of the CYP2B6 genetic background on the development of specific chromosomal aberrations. |
format | Online Article Text |
id | pubmed-3933334 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-39333342014-02-25 The G(516)T CYP2B6 Germline Polymorphism Affects the Risk of Acute Myeloid Leukemia and Is Associated with Specific Chromosomal Abnormalities Daraki, Aggeliki Zachaki, Sophia Koromila, Theodora Diamantopoulou, Paraskevi Pantelias, Gabriel E. Sambani, Constantina Aleporou, Vasiliki Kollia, Panagoula Manola, Kalliopi N. PLoS One Research Article The etiology of acute myeloid leukemia (AML) underlies the influence of genetic variants in candidate genes. The CYP2B6 enzyme detoxifies many genotoxic xenobiotics, protecting cells from oxidative damage. The CYP2B6 gene is subjected to a single-nucleotide polymorphism (G(516)T) with heterozygotes (GT) and homozygotes (TT) presenting decreased enzymatic activity. This case-control study aimed to investigate the association of CYP2B6 G(516)T polymorphism with the susceptibility of AML and its cytogenetic and clinical characteristics. Genotyping was performed on 619 AML patients and 430 healthy individuals using RCR-RFLP and a novel LightSNip assay. The major finding was a statistically higher frequency of the variant genotypes (GT and TT) in patients compared to the controls (GT:38.8% vs 29.8% and TT:9.3% vs 5.3% respectively) (p<0.001). More specifically, a significantly higher frequency of GT+TT genotypes in de novo AML patients (46.6%) and an immensely high frequency of TT in secondary AML (s-AML) (20.5%) were observed. The statistical analysis showed that the variant T allele was approximately 1.5-fold and 2.4-fold higher in de novo and s-AML respectively than controls. Concerning FAB subtypes, the T allele presented an almost 2-fold increased in AML-M2. Interestingly, a higher incidence of the TT genotype was observed in patients with abnormal karyotypes. In particular, positive correlations of the mutant allele were found in patients carrying specific chromosomal aberrations [-7/del(7q), -5/del(5q), +8, +21 or t(8;21)], complex or monosomal karyotypes. Finally, a strikingly higher frequency of TT genotype was also observed in patients stratified to the poor risk group. In conclusion, our results provide evidence for the involvement of the CYP2B6 polymorphism in AML susceptibility and suggest a possible role of the CYP2B6 genetic background on the development of specific chromosomal aberrations. Public Library of Science 2014-02-24 /pmc/articles/PMC3933334/ /pubmed/24586425 http://dx.doi.org/10.1371/journal.pone.0088879 Text en © 2014 Daraki et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Daraki, Aggeliki Zachaki, Sophia Koromila, Theodora Diamantopoulou, Paraskevi Pantelias, Gabriel E. Sambani, Constantina Aleporou, Vasiliki Kollia, Panagoula Manola, Kalliopi N. The G(516)T CYP2B6 Germline Polymorphism Affects the Risk of Acute Myeloid Leukemia and Is Associated with Specific Chromosomal Abnormalities |
title | The G(516)T CYP2B6 Germline Polymorphism Affects the Risk of Acute Myeloid Leukemia and Is Associated with Specific Chromosomal Abnormalities |
title_full | The G(516)T CYP2B6 Germline Polymorphism Affects the Risk of Acute Myeloid Leukemia and Is Associated with Specific Chromosomal Abnormalities |
title_fullStr | The G(516)T CYP2B6 Germline Polymorphism Affects the Risk of Acute Myeloid Leukemia and Is Associated with Specific Chromosomal Abnormalities |
title_full_unstemmed | The G(516)T CYP2B6 Germline Polymorphism Affects the Risk of Acute Myeloid Leukemia and Is Associated with Specific Chromosomal Abnormalities |
title_short | The G(516)T CYP2B6 Germline Polymorphism Affects the Risk of Acute Myeloid Leukemia and Is Associated with Specific Chromosomal Abnormalities |
title_sort | g(516)t cyp2b6 germline polymorphism affects the risk of acute myeloid leukemia and is associated with specific chromosomal abnormalities |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933334/ https://www.ncbi.nlm.nih.gov/pubmed/24586425 http://dx.doi.org/10.1371/journal.pone.0088879 |
work_keys_str_mv | AT darakiaggeliki theg516tcyp2b6germlinepolymorphismaffectstheriskofacutemyeloidleukemiaandisassociatedwithspecificchromosomalabnormalities AT zachakisophia theg516tcyp2b6germlinepolymorphismaffectstheriskofacutemyeloidleukemiaandisassociatedwithspecificchromosomalabnormalities AT koromilatheodora theg516tcyp2b6germlinepolymorphismaffectstheriskofacutemyeloidleukemiaandisassociatedwithspecificchromosomalabnormalities AT diamantopoulouparaskevi theg516tcyp2b6germlinepolymorphismaffectstheriskofacutemyeloidleukemiaandisassociatedwithspecificchromosomalabnormalities AT panteliasgabriele theg516tcyp2b6germlinepolymorphismaffectstheriskofacutemyeloidleukemiaandisassociatedwithspecificchromosomalabnormalities AT sambaniconstantina theg516tcyp2b6germlinepolymorphismaffectstheriskofacutemyeloidleukemiaandisassociatedwithspecificchromosomalabnormalities AT aleporouvasiliki theg516tcyp2b6germlinepolymorphismaffectstheriskofacutemyeloidleukemiaandisassociatedwithspecificchromosomalabnormalities AT kolliapanagoula theg516tcyp2b6germlinepolymorphismaffectstheriskofacutemyeloidleukemiaandisassociatedwithspecificchromosomalabnormalities AT manolakalliopin theg516tcyp2b6germlinepolymorphismaffectstheriskofacutemyeloidleukemiaandisassociatedwithspecificchromosomalabnormalities AT darakiaggeliki g516tcyp2b6germlinepolymorphismaffectstheriskofacutemyeloidleukemiaandisassociatedwithspecificchromosomalabnormalities AT zachakisophia g516tcyp2b6germlinepolymorphismaffectstheriskofacutemyeloidleukemiaandisassociatedwithspecificchromosomalabnormalities AT koromilatheodora g516tcyp2b6germlinepolymorphismaffectstheriskofacutemyeloidleukemiaandisassociatedwithspecificchromosomalabnormalities AT diamantopoulouparaskevi g516tcyp2b6germlinepolymorphismaffectstheriskofacutemyeloidleukemiaandisassociatedwithspecificchromosomalabnormalities AT panteliasgabriele g516tcyp2b6germlinepolymorphismaffectstheriskofacutemyeloidleukemiaandisassociatedwithspecificchromosomalabnormalities AT sambaniconstantina g516tcyp2b6germlinepolymorphismaffectstheriskofacutemyeloidleukemiaandisassociatedwithspecificchromosomalabnormalities AT aleporouvasiliki g516tcyp2b6germlinepolymorphismaffectstheriskofacutemyeloidleukemiaandisassociatedwithspecificchromosomalabnormalities AT kolliapanagoula g516tcyp2b6germlinepolymorphismaffectstheriskofacutemyeloidleukemiaandisassociatedwithspecificchromosomalabnormalities AT manolakalliopin g516tcyp2b6germlinepolymorphismaffectstheriskofacutemyeloidleukemiaandisassociatedwithspecificchromosomalabnormalities |